AlgaeNite
Opportunity: The $195b fertilizer industry has been dominated by and dependent on fundamentally outdated methods of the production and delivery of fertilizer to the world’s farms for more than a century. Recognized as being in crisis, the fertilizer market is ripe for disruption. Challenges: Fertilizer supply chains have become notoriously unreliable, and energy costs associated with fertilizer production have spiked, ultimately causing what many refer to as the “fertilizer crisis,” one which threatens the world’s food supply and the economic viability of farms all over the world. Solution: Algaenite has patented a process that overturns our concepts around fertilizer production and delivery to solve the problems facing both farmers and the fertilizer industry. Produced by the company’s bio-reactors, AlgaeNite’s “bio-ammonia” fertilizer is rich in the “available nitrogen” plants need, far outperforming other organic fertilizers in both cost and yield, matching the yield of the best modern chemical fertilizers. Using a nitrogen-fixing cyanobacteria, the cost-competitive AlgaeNite fertilizer production process extracts nitrogen from the air, produces zero greenhouse gases (negative CO2 emissions) and requires far less energy than chemical fertilizers. Significantly, AlgaeNite’s bio-reactors allow farms of all sizes to easily produce their own organic fertilizer on site, using only water, energy from the sun and nitrogen from the air. AlgaeNite not only stands to disrupt the nitrogen fertilizer industry, but aims to pave a path to sustainable and economical production of food for the world’s growing population. The company’s technology is also applicable to animal feed, alt-meat proteins, bioplastics and cosmetics. Funding: AlgaeNite is currently raising $10m to fund further R&D in Israel and the establishment of a U.S. marketing and business development entity. AlgaeNite forecasts reaching profitability in year three and expects to install a total of 160 commercial bio-reactor units by year five, by which time the company will have accumulated $56m in cash.
Opportunity: The $195b fertilizer industry has been dominated by and dependent on fundamentally outdated methods of the production and delivery of fertilizer to the world’s farms for more than a century. Recognized as being in crisis, the fertilizer market is ripe for disruption. Challenges: Fertilizer supply chains have become notoriously unreliable, and energy costs associated with fertilizer production have spiked, ultimately causing what many refer to as the “fertilizer crisis,” one which threatens the world’s food supply and the economic viability of farms all over the world. Solution: Algaenite has patented a process that overturns our concepts around fertilizer production and delivery to solve the problems facing both farmers and the fertilizer industry. Produced by the company’s bio-reactors, AlgaeNite’s “bio-ammonia” fertilizer is rich in the “available nitrogen” plants need, far outperforming other organic fertilizers in both cost and yield, matching the yield of the best modern chemical fertilizers. Using a nitrogen-fixing cyanobacteria, the cost-competitive AlgaeNite fertilizer production process extracts nitrogen from the air, produces zero greenhouse gases (negative CO2 emissions) and requires far less energy than chemical fertilizers. Significantly, AlgaeNite’s bio-reactors allow farms of all sizes to easily produce their own organic fertilizer on site, using only water, energy from the sun and nitrogen from the air. AlgaeNite not only stands to disrupt the nitrogen fertilizer industry, but aims to pave a path to sustainable and economical production of food for the world’s growing population. The company’s technology is also applicable to animal feed, alt-meat proteins, bioplastics and cosmetics. Funding: AlgaeNite is currently raising $10m to fund further R&D in Israel and the establishment of a U.S. marketing and business development entity. AlgaeNite forecasts reaching profitability in year three and expects to install a total of 160 commercial bio-reactor units by year five, by which time the company will have accumulated $56m in cash.
AlgaeNite has raised $260k across 1 round. Its most recent round was a Seed of $260k in Apr 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.
AlgaeNite is featured in
Similar companies
Swish Basket is an AI-powered basketball training and gaming platform that provides personalized coaching feedback services.
Remepy is biotechnology research pioneering hybrid drugs.
Corma develops foundation models and artificial intelligence systems for defensive cybersecurity.
Faye provides whole-trip travel coverage and care that brings out the best in each journey with industry-leading technology that enables smarter, faster, smoother assistance and claims resolutions. Our robust travel insurance covers your health, your trip, your stuff, and even your pet, via an app that provides real-time proactive solutions, quick reimbursements and 24/7 customer experience specialists who turn travel mishaps into laugh-about-it-later memories. Join our team of travel and insurance experts as we set a new standard by overdelivering in an industry oftentimes synonymous with doing the opposite.
By utilising runtime application context and leveraging the most exact open source security solution available, Oligo, performance and stability are maintained. Customers who use Oligo may save time and concentrate on the pertinent runtime vulnerabilities, which reduces the effort of reacting to security alerts by roughly 85%.
QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.
Above Security provides cybersecurity services focused on threat detection, risk management, and compliance support for organizations. Its offerings include managed security services, vulnerability assessments, penetration testing, and incident response to help identify and address security risks. The company also delivers security operations center capabilities that monitor and analyze network activity to detect potential threats. In addition, it supports governance, risk, and compliance programs by helping organizations align with regulatory requirements and security frameworks. Its services are designed to assist businesses in maintaining visibility over their systems and improving overall security posture.
Zenity is a leading company that assists businesses in securing and managing AI Agents and Apps. The era of AI has given business users unprecedented control over the development of business applications, with AI Agents now being created and controlled by these users. However, many existing security tools are not equipped to handle the unique challenges posed by business-led development. Zenity's platform is designed with a strong emphasis on security, focusing on Visibility, Risk Assessment, and Governance. As a founding member of the OWASP Top 10 project and the Gen AI Attacks Matrix, Zenity takes a collaborative approach to address security concerns in low-code/no-code development. Compliant with SOC 2 Type 2 and GDPR regulations, Zenity's platform helps businesses understand their apps, mitigate risks, comply with regulations, and support business-led development.
Xsight Labs is an Israeli company that develops technology for accelerating the next-generation, cloud-based, data-intensive workloads such as machine learning by offering new chipset designs that enhance scalability, performance and efficiency.
Cytactic is a company that specializes in cyber crisis management, offering services such as advisory, simulations, and assessments.
groundcover is a K8s application monitoring solution that reinvents the domain with eBPF.
Hush Security is a cybersecurity company specializing in eliminating static secrets like API keys and credentials.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.